Literature DB >> 18460460

Update in cystic fibrosis 2007.

Frank J Accurso1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18460460      PMCID： PMC2720148          DOI： 10.1164/rccm.200801-069UP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  29 in total

Review 1.  Outcome measures for development of new therapies in cystic fibrosis: are we making progress and what are the next steps?

Authors:  Bonnie W Ramsey
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

Review 2.  Cystic fibrosis.

Authors:  Jane C Davies; Eric W F W Alton; Andrew Bush
Journal:  BMJ       Date:  2007-12-15

3.  Heritability of lung disease severity in cystic fibrosis.

Authors:  Lori L Vanscoy; Scott M Blackman; Joseph M Collaco; Amanda Bowers; Teresa Lai; Kathleen Naughton; Marilyn Algire; Rita McWilliams; Suzanne Beck; Julie Hoover-Fong; Ada Hamosh; Dave Cutler; Garry R Cutting
Journal:  Am J Respir Crit Care Med       Date:  2007-03-01       Impact factor: 21.405

4.  High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial.

Authors:  Larry C Lands; Ruth Milner; André M Cantin; David Manson; Mary Corey
Journal:  J Pediatr       Date:  2007-06-26       Impact factor: 4.406

5.  Synergistic airway gland mucus secretion in response to vasoactive intestinal peptide and carbachol is lost in cystic fibrosis.

Authors:  Jae Young Choi; Nam Soo Joo; Mauri E Krouse; Jin V Wu; Robert C Robbins; Juan P Ianowski; John W Hanrahan; Jeffrey J Wine
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

6.  Host resistance to lung infection mediated by major vault protein in epithelial cells.

Authors:  Michael P Kowalski; Anne Dubouix-Bourandy; Milan Bajmoczi; David E Golan; Tanweer Zaidi; Yamara S Coutinho-Sledge; Melanie P Gygi; Steven P Gygi; Erik A C Wiemer; Gerald B Pier
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

7.  Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial.

Authors:  Richard B Moss; Carlos Milla; John Colombo; Frank Accurso; Pamela L Zeitlin; John P Clancy; L Terry Spencer; Joseph Pilewski; David A Waltz; Henry L Dorkin; Thomas Ferkol; Mark Pian; Bonnie Ramsey; Barrie J Carter; Dana B Martin; Alison E Heald
Journal:  Hum Gene Ther       Date:  2007-08       Impact factor: 5.695

8.  A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients.

Authors:  Gerd Döring; Christoph Meisner; Martin Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-21       Impact factor: 11.205

9.  Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis.

Authors:  Robin R Deterding; Lisa M Lavange; Jean M Engels; Dave W Mathews; Sarah J Coquillette; Alan S Brody; Steve P Millard; Bonnie W Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2007-04-19       Impact factor: 21.405

10.  A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.

Authors:  Dirk Schnabel; Corinna Grasemann; Doris Staab; Hartmut Wollmann; Felix Ratjen
Journal:  Pediatrics       Date:  2007-06       Impact factor: 7.124
View more
  9 in total

1.  Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy.

Authors:  Nadzeya V Marozkina; Sean Yemen; Molly Borowitz; Lei Liu; Melissa Plapp; Fei Sun; Rafique Islam; Petra Erdmann-Gilmore; R Reid Townsend; Cheryl F Lichti; Sneha Mantri; Phillip W Clapp; Scott H Randell; Benjamin Gaston; Khalequz Zaman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-08       Impact factor: 11.205

2.  Factors associated with parental perception of child vulnerability 12 months after abnormal newborn screening results.

Authors:  Audrey Tluczek; Anne Chevalier McKechnie; Roger L Brown
Journal:  Res Nurs Health       Date:  2011-08-24       Impact factor: 2.228

3.  Factors affecting nebulised medicine adherence in adult patients with cystic fibrosis: a qualitative study.

Authors:  Alice Hogan; Mary-Ann Bonney; Jo-Anne Brien; Rita Karamy; Parisa Aslani
Journal:  Int J Clin Pharm       Date:  2014-11-29

4.  When the cystic fibrosis label does not fit: a modified uncertainty theory.

Authors:  Audrey Tluczek; Anne Chevalier McKechnie; Patrice A Lynam
Journal:  Qual Health Res       Date:  2010-02

5.  Adherence with tobramycin inhaled solution and health care utilization.

Authors:  Becky A Briesacher; Alexandra L Quittner; Lisa Saiman; Patricia Sacco; Hassan Fouayzi; Lynne M Quittell
Journal:  BMC Pulm Med       Date:  2011-01-20       Impact factor: 3.317

6.  The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics.

Authors:  Atqah AbdulWahab; Khalid Zahraldin; Mazen A Sid Ahmed; Sulieman Abu Jarir; Mohammed Muneer; Shehab F Mohamed; Jemal M Hamid; Abubaker A I Hassan; Emad Bashir Ibrahim
Journal:  Lung India       Date:  2017 Nov-Dec

7.  The correlation of brody high resolution computed tomography scoring system with clinical status and pulmonary function test in patients with cystic fibrosis.

Authors:  Soheila Khalilzadeh; Shahram Kahkouee; Maryam Hassanzad; Nazanin Parsanejad; Nooshin Baghaie; Mohammad Reza Bloorsa
Journal:  Iran J Med Sci       Date:  2011-03

8.  Analysis and Characterization of Staphylococcus aureus Small Colony Variants Isolated From Cystic Fibrosis Patients in Austria.

Authors:  Lilian Masoud-Landgraf; Gernot Zarfel; Tanja Kaschnigg; Simone Friedl; Gebhard Feierl; Ute Wagner-Eibel; Ernst Eber; Andrea J Grisold; Clemens Kittinger
Journal:  Curr Microbiol       Date:  2016-01-28       Impact factor: 2.188

9.  Investigating the Temporal Relationships between Symptoms and Nebuliser Adherence in People with Cystic Fibrosis: A Series of N-of-1 Observations.

Authors:  Rosie Martin; Madelynne Arden; Jenny Porritt; Martin Wildman; Felix Naughton
Journal:  Healthcare (Basel)       Date:  2020-01-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.